We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Bayer Aktiengesellschaft (PK) | USOTC:BAYRY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 7.60 | 7.59 | 7.68 | 7.69 | 7.59 | 7.66 | 2,551,609 | 21:30:14 |
From May 2021 to May 2024
By Cecilia Butini
Bayer AG said Friday that it would invest more than 1.3 billion euros ($1.44 billion) in its impact investment unit Leaps by Bayer over the next three years as it seeks to drive innovation in the life sciences domain.
The German pharmaceutical and agricultural company said it has already invested more than EUR1.3 billion over the past seven years in more than 50 companies that focus on innovation in health and agriculture.
According to Bayer, "a forthcoming wave of innovations will open new opportunities in next-generation healthcare and [provide] farming solutions to make agriculture more sustainable and less resource intensive." Chief Executive Werner Baumann said that Bayer would step up its efforts in order to be a driver of this innovation.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
April 01, 2022 07:33 ET (11:33 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Bayer Aktiengesellschaft (PK) Chart |
1 Month Bayer Aktiengesellschaft (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
